IPO Boutique

Obalon Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Obalon Therapeutics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Obalon TherapeuticsOBLN -
NASDAQ
$14.00-$16.00 $15.00 $15.215 million10/6/2016
UBS Investment Bank, Canaccord Genuity, Stifel
Co-Manager(s):
BTIG
Health Care
Filing(s):

Filed 2016-09-09
Terms Added 2016-09-26



Obalon Therapeutics Quote & Chart - Click for current quote - OBLN

About Obalon Therapeutics (adapted from Obalon Therapeutics prospectus):
They are a commercial-stage medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "OBLN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved